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Purpose
The purpose of the study was to evaluate the effective-
ness of ALDEA (Latinos con Diabetes en Acción), a 
Shared Medical Appointment (SMA) intervention, com-
pared to usual primary care (UPC) for the treatment of 
adults with type 2 diabetes over a 6-month period. It was 
hypothesized that participants in the SMA will have 
greater reductions in A1C at 6 months post-intervention 
compared to the control group.
Methods
This study was a quasi-experimental design with a non-
randomized matched control group that followed partici-
pants prospectively for 6 months. All adults living with 
type-2 diabetes receiving primary care at a 2 FQHC clinics 
were eligible for inclusion. Participants in the control group 
were matched retrospectively on baseline A1C and age.
Results
The reductions in A1C were greater in the ALDEA SMA 
intervention group relative to the UPC control group at 6 
months in both of the FQHC centers and in the combined 
sample.
Conclusions
This study demonstrated that patients in the ALDEA 
program had a significantly greater reduction in A1C at 
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6 months compared to the control group. Despite its 
limitations, the ALDEA SMA program was successful in 
empowering patients and improving glycemic control.
D
iabetes has reached epidemic proportions 
in the United States. In 2017, the Centers 
for Disease Control and Prevention 
reported that approximately 30.3 million 
people have diabetes, representing 9.4% 
of the US population.1 Disparities in the prevalence rates 
of type 2 diabetes and quality of diabetes care are found 
at the intersection of class, race, and ethnicity. People 
who are uninsured and people of lower socioeconomic 
status suffer disproportionally high morbidity and dis-
ability from diabetes.2 For people with diabetes confront-
ing structural barriers to health, such as lack of health 
insurance and/or transportation, poverty, racism, and 
food insecurity, diabetes self-management education is 
often not attainable.3,4 Federally Qualified Health Centers 
(FQHCs) are at the forefront of providing care to medi-
cally underserved communities.5
Despite a steady and slow improvement over the past 
10 years in achieving recommended goals for glycated 
hemoglobin (A1C), blood pressure (BP), and low density 
lipoprotein (LDL), about half of the adults with diabetes 
continue to miss target goals (33%-49%).6 Nationally, 
only 19% of adults with diabetes meet all 3 target goals 
(A1C, BP, and LDL) and are nonsmokers.6 Furthermore, 
only half of adults with diabetes have had formal diabe-
tes self-management education and support (DSMES) 
despite the American Diabetes Association (ADA) rec-
ommendation and the mounting evidence supporting 
DSMES as a critical component of diabetes care.6,7
Shared medical appointments (SMAs) have become an 
increasingly popular model to improve the quality of diabe-
tes care and access to education.8-12 SMAs are a promising 
alternative to individual office visits because DSMES and 
peer support are integrated within the SMA visit, collabora-
tive relationships between providers and patients can be 
nurtured, and group activities can be used to refine patients’ 
disease management skills and enhance knowledge.13
Research on the effectiveness of SMAs to improve 
diabetes outcomes for adults with type 2 diabetes has 
emerged, and there is sufficient evidence on the positive 
impact of SMAs on important outcomes, A1C and BP. 
Unfortunately, the current literature on SMA effectiveness 
has, for the most part, excluded monolingual Spanish-
speaking Latinos (MSL) and other racial and ethnic 
minorities despite these populations’ disproportionate 
burden of the disease.14 A recent study by Noya and col-
leagues15 demonstrated that a culturally adapted SMA 
model among monolingual Latinxs was effective in reduc-
ing A1C at 6 months an additional 0.83% compared to the 
control group (b = −0.83, t = −2.25, P = .03 ). Therefore, 
there is support for the implementation of SMAs among 
adults with type 2 diabetes.8,13,15 Two separate meta-anal-
yses revealed that SMAs improved A1C by 0.6% to 
0.7%.8,13 Although a change of 0.6% to 0.7% may seem 
modest, based on the United Kingdom Prospective 
Diabetes Study (UKPDS) findings,16 a decrease of 0.6% 
A1C translates to a decrease of approximately 10.5% of 
the overall deaths related to diabetes, 7% of the myocar-
dial infarctions, and 19% of microvascular complications.
Although the literature demonstrates that SMAs 
improve outcomes in patients with type 2 diabetes, there 
are also a number of identified barriers to participation in 
educational programs. In a recent metanalysis, these 
were identified as either those who could not attend 
(logistical, medical, or financial barriers) or those who 
choose not to attend (no perceived benefit, cultural bar-
rier, knowledge).17 One study specifically examining 
Latinx patients’ participation in SMA noted lack of cul-
turally relevant marketing and scheduling barriers as 
likely barriers to participation.18
The present study was part of an academic-community 
partnership aimed to improve the care of adults with type 2 
diabetes living in 2 different rural counties in Northern 
California. Informed written consent was obtained in English 
or Spanish. The Institutional Review Board at the University 
of California, San Francisco approved the study, including 
the protocol and consent forms (IRB No. 16-21252).
The purpose of this study is to evaluate the effective-
ness of the ALDEA SMA Program (Latinos con Diabetes 
en Acción) at 2 rural FQHCs with a multiethnic group of 
adults with type 2 diabetes, compared to usual primary 
care (UPC) over a 6-month period.
Study Design
Design
This study was a quasi-experimental design with a 
nonrandomized matched UPC control group that fol-
lowed patients prospectively for 6 months.
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Hypothesis
It was hypothesized that participants in the ALDEA 
SMA would have greater reductions in A1C at 3- and 
6-months postintervention compared to the UPC control 
group.
Methodology
The methodology will be described in 2 sections: first, 
the methodology that is shared by both sites followed by 
each site’s unique characteristics.
Sample Selection
Inclusion criteria required patients >18 years of age 
with type 2 diabetes and attendance of at least 3 SMA 
sessions over the course of the program. Patients were 
referred by their primary care providers, medical assis-
tants, and/or health educators. They were recruited via 
flyers and phone calls using the diabetes registry at the 
FQHCs. The UPC control group was a retrospective, 
nonrandom, matched sample who met the aforemen-
tioned inclusion criteria and received UPC at the FQHC 
site. The UPC control group was selected via medical 
record review. Each intervention participant was matched 
by age (within 5 years) and A1C levels (within 0.5%-1%) 
with a UPC control group participant. Each SMA partici-
pant was matched with their controls within the same 
timeframe of the intervention so that baseline and follow-
up data were consistent over time.
All patients with an A1C >9% were offered participa-
tion in the intervention. Due to the extensive outreach 
including flyers, we are unable to know how many eligible 
patients were aware of the SMA program. Written consent 
in both English and Spanish was available. Patients pro-
vided consent in their language of preference prior to the 
start of the study. Based on previous literature, we hypoth-
esized that the intervention group’s average change in 
A1C from baseline to 6 months would be 1.48% (SD = 
2.22).15 It was hypothesized that the control group would 
have no change in A1C. The difference between a 1.48 
(2.22) mean (SD) change and no change can be expressed 
as an effect size of .667. Using the nQuery Advisor power 
program for a t test with unequal sample sizes between 2 
independent groups, with a 1:2 ratio, 80% power to detect 
the effect size of .667, and a 2-tailed alpha of .05, the total 
sample size would need to be 84 (eg, 28 intervention and 
56 control group participants).
Table 1
Cultural Adaptation of ALDEA Shared Medical Appointment Model
Issues to Consider Adaptation
Philosophy • Empowerment model
• Patient driven; patient as experts
Patient education • Patient-driven curriculum
• Adapted for low health literacy
•  Behavioral approaches (motivational interviewing, SMART goals, problem solving)
Social determinants Low SES/insurance status • Low-cost pharmacy
• Low-cost/free diabetes supplies
LHL
Food insecurity
• Screening for LHL included in intake form
• Food distribution established on site
Language barriers • Bicultural and bilingual team
Cultural considerations Respeto • Cultural humility training for bicultural and bilingual team
Familismo • Family members invited to participate
• Consideration of family in planning and execution of SMART goals
Time orientation • Flexible schedule, late arrival normalized
Herbal medicine • Use of herbal medicine integrated into intake form
Abbreviations: LHL, low health literacy; SES, socioeconomic status.
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Intervention: ALDEA SMA
ALDEA is a culturally tailored SMA program. The 
structure of the SMA intervention was based on the model 
refined by the Veterans Affairs Office.11 In this model, 
groups include peer support, DSMES with a focus on 
behavioral approaches (SMART goals and problem solv-
ing), and medical management. SMART goals are spe-
cific, measurable, agreed on, realistic, and time-based. The 
ALDEA model is unique in that it does not have a set cur-
riculum, maintains open enrollment, and has a flexible late 
policy. Topics are decided on by participants rather than by 
the provider or health educator. Open enrollment allows 
participants to join the group at any point of time. 
Additionally, participants have flexibility in attendance 
and are permitted to join even if late or having missed 
group sessions. Each of the FQHC partners adhered to the 
main characteristics of the ALDEA program, with a bilin-
gual and bicultural health care team to support an open 
enrollment program that was based off of an empower-
ment model with a patient-driven, culturally specific cur-
riculum while utilizing behavioral approaches with patients 
and families (motivational interviewing, setting SMART 
goals, and using problem solving strategies). Table 1 pro-
vides a description of adaptive changes made to the model.
Clinical partners had autonomy in deciding the fre-
quency of their SMA program and the composition of the 
health care team. The health care team differed in that 
Site 1 had a nurse practitioner as the lead clinician, and 
Site 2 had a physician as the lead clinician. Both FQHC 
SMA teams included a medical assistant, a health educa-
tor, and a front office administrator. Additionally, the 
periodicity and intensity of the SMA interventions varied 
between sites, with Site 1 offering weekly sessions and 
Site 2 offering SMA bimonthly. At Site 2, an education 
group was offered during the alternate weeks.
Control: Usual Primary Care
The UPC patients received the standard of care for 
patients with diabetes consisting of quarterly individual 
medical visits with a primary care provider (ie, MD, family 
nurse practitioner [FNP], or physician’s assistant [PA]) of 
approximately 20 minutes. Referrals to DSMES in the 
community were made routinely as part of standard of care.
Setting
Two FQHC clinics were identified from within a con-
sortium of 13 FQHC networks that serve as primary care 
medical homes to a diverse population of medically 
underserved individuals and families located in the 
Central Valley (CV) of California. The CV is the fastest 
growing region in California and one of the most pro-
ductive agricultural regions in the world. The CV is 
comprised of 19 counties, ranging from isolated rural 
agricultural areas to rapidly expanding urban centers. 
This FQHC consortium serves more than 600 000 
patients annually in more than 145 community health 
centers; migrant and seasonal farmworkers make up 
over 40% of patients served. An area of high health care 
needs, all CV counties include federally designated 
health professional shortage areas.19 Clients from within 
these FQHCs experience high rates of chronic health 
conditions, such as diabetes, obesity, and asthma, and 
are at high risk for poor pregnancy and birth outcomes, 
including preterm birth.20
Site 1 is at an FQHC located in the northeast sector of the 
CV, a generally rural, agricultural district with a large 
migrant worker population. They serve 87 000 patients 
annually, 90% of whom earn below 200% of the federal 
poverty level; 87% are non-English speakers; and 12% 
are migrant or seasonal farmworkers. At this location, 2 
separate groups were formed, 1 for Spanish-speaking 
Latinxs and 1 for all English speakers.
Site 2 is at an FQHC located in the heart of the CV providing 
care to 26 735 patients annually. The patient population is 
predominantly Latinx (74%), 31% is best served in 
another language (primarily Spanish), 96% earns below 
200% of the federal poverty level, 73% is insured by 
Medi-Cal, and 21% are migrant or seasonal workers. At 
this site, a single group for Spanish-speaking Latinxs was 
implemented.
Measures
Demographic variables were obtained from the medi-
cal records retrospectively for the intervention and UPC 
control group patients, as were laboratory values of A1C, 
systolic and diastolic BP, and LDL at baseline, 3 months 
and 6 months after baseline.
Demographic Variables
The following demographic data were collected at 
baseline: chronological age (in years), sex, ethnicity 
(patients’ self-identification), poverty level (per federal 
guidelines), and health insurance (yes or no for any type 
of comprehensive insurance, public or private payer).
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Outcome/Metabolic Variables
A1C was measured with a high-performance liquid 
chromatography method used by the Bio-Rad Hercules 
laboratory. Data were obtained at baseline and 3 and 6 
months. If a participant had more than 1 measurement in a 
90-day interval, the average of all A1C levels collected 
during the interval was used. A1C levels obtained within 
24 hours of the first SMA appointment were considered to 
be pre-SMA baseline data. Post-SMA data points were cal-
culated as time from first SMA appointment. Data from all 
patients were then aggregated based on corresponding 
time intervals every 3 months. Quarterly measures of A1C 
are part of the ADA guidelines of care for people with dia-
betes and were routinely collected in this clinic.
The value of the last LDL closest to the 6-month pos-
tintervention data collection point was utilized. Per cur-
rent ADA guidelines, the LDL variable was dichotomized 
(yes/no) as to whether the participant achieved the rec-
ommendation of LDL <100 mg/dL.21
Blood pressure, both systolic (SBP) and diastolic 
(DBP), were measured using calibrated manual cuffs, 
taken by a medical assistant or nurse practitioner student at 
each clinic or SMA visit. Blood pressure values closest to 
the 6-month time postbaseline data collection point were 
used for analysis. Per current guidelines, the BP variable 
was dichotomized (yes/no) as to whether the participant 
achieved the ADA recommendation of <140/90 mmHg.21
Data Analysis
Data entry and statistical analyses were conducted 
using SPSS 19. Descriptive statistics were used to sum-
marize the data and identify outliers. Differences in the 
demographics and study variables between the SMA 
intervention group and the UPC control group were cal-
culated using Student’s t test for independent groups, chi-
square, or Fisher exact tests
To test the effect of the SMA intervention on A1C 
change, differences in change scores were compared 
between the ALDEA SMA intervention group and the 
UPC. Change scores were operationalized as the reduc-
tion in A1C at 3 months (3 months - baseline) and reduc-
tion at 6 months (6 months – baseline). Multiple linear 
regression analyses were conducted to assess if mean 
A1C change from baseline to 3 and 6 months was greater 
among SMA intervention group patients compared to the 
UPC control group patients. Baseline A1C and clinic 
(site) were entered as covariates in the model. Regression 
analysis is an approach that has been supported in the 
literature as a valid method to examine change scores.22 
Moreover, it provides data that are more easily interpre-
table in the clinical setting, for example, the difference in 
the amount of change in A1C (change score) between 
intervention and control groups.
Logistic regression analyses were conducted to test 
the effect of the SMA intervention on achieving target 
goals for BP and LDL at 6 months. These variables were 
dichotomized and coded as on target (1) and not on target 
(0); BP <140/90 and LDL <100 per current guidelines.23 
Clinic (site) was entered as a covariate in the model.
Results
Sample
Site 1: The nonprobability convenience sample consisted of 
84 patients receiving primary care at an FQHC clinic, 
with the SMA intervention group (n = 29) and UPC con-
trol group (n = 55). A ratio of 2 to 1 was chosen to 
achieve sufficient power.
There were a total of 24 SMA sessions during the first 
6 months of the program. The mean age of the SMA 
group was 55 years ± 12, sex of patients was balanced 
across groups, with equal numbers of females and males 
in each group. Approximately half the SMA group was of 
Latinx origin and monolingual Spanish speaking. All of 
the patients were at or below 100% of the federal poverty 
line and had similar rates of health insurance. At base-
line, there were no statistically significant differences in 
age (P = .32), sex (P = .58), poverty, or health insurance 
status (P = .84) between the SMA intervention group and 
the matched UPC control group (Table 2).
Site 2: The nonprobability convenience sample consisted of 
55 patients receiving primary care at an FQHC clinic, 
with the SMA intervention group (n = 18) and UPC con-
trol group (n = 37).
There were a total of 12 SMA sessions during the first 
6 months of the program. Each session included a mean of 
7 patients. The mean age of the sample was 53 ± 11 years. 
All of the patients were at or below the federal poverty 
line, and approximately 67% had health insurance (Table 
2). At baseline, there were no statistically significant dif-
ferences in age (P = .92), sex (P = .86), poverty level, or 
health insurance status (P = .78) between the SMA inter-
vention group and the matched UPC control group.
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Table 2
Demographic Characteristics of Study Participants
Site 1 Site 2
SMA 
(n = 29)
Control 
(n = 55) P
SMA 
(n = 18)
Control 
(n = 37) P
Age, y, mean (SD) 55 (±11.7) 55 (±11.7) .32 53 (±11.2) 53 (±10.6) .92
Sex (% F/M) 50/50 50/50 .58 72/28 73/27 .86
Ethnicity, %
 Latinx 56.7 44.8 100 100
 African American 13.3 10.3
 American Indian/Alaskan Native 3.3 1.7
 Asian 6.7 10.3
 White 20.0 31.0
Native language, %
 English 56.7 56.4
 Spanish 43.3 48.3 100 100
 Hmong 3.4
 Tagalog 1.7
 Declined 3.4
% Below 100% federal poverty level 100 100 100 100
% Has insurance 73 70 .84 65 68 .78
Table 3
Clinical Characteristics of Study Participants
Clinical parameters 
Site 1
ALDEA SMA 
(n = 29)
Control 
(n = 55)
M SD M SD P
A1C, baseline 9.75 1.86 9.73 1.97 .95
A1C, month 3 8.82 1.44 9.29 1.74 .28
A1C, month 6 8.63 1.91 9.30 2.13 .23
Site 2 n = 18 n = 37
A1C, baseline 9.12 1.90 8.89 1.60 .69
A1C, month 3 7.93 1.49 9.2 2.26 .08
A1C, month 6 7.39 1.71 7.79 1.79 .51
Abbreviation: SMA, shared medical appointment.
Shared Medical Appointments
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A1C
Cross-sectionally, there were no statistically signifi-
cant differences on average A1C values between SMA 
and control groups at baseline, 3 months, and 6 months 
for either clinical site. (Table 3).
Multiple regression analysis demonstrated that com-
pared to the UPC, the SMA group had a statistically 
significant change in A1C at 3 months, F(3, 82) = 14.7, 
P = .00, and 6 months, F(3, 98) = 11.5, P = .00 (Table 4). 
There was an additional reduction of A1C of −.71%, b = 
−0.71, t(2) = −2.23, P = .03, from baseline to 3 months 
and a statistically significant reduction of −.80%, b = 
−0.80, t(2) = −2.34, P = .02, from baseline to 6 months, 
in favor of SMA participants. The clinic site was not 
significant in the model (.34%), b = .34, t(1) = 1.04, P = 
.30, at 3 months, but it was at 6 months in favor of site 1 
(.78%), b = 0.78, t(1) = 2.29, P = .02.
Logistic regression analyses showed no significant 
difference between SMA and UPC control group patients 
in achieving BP target, b = 0.27, Wald(1) = .36, P = .55, 
or LDL target, b = 0.64, Wald(1) = 2.6, P = .11, at 6 
months. Clinic site was not significant predicting BP, b = 
0.27, Wald(1) = .36, P = .55, or LDL b = 0.64, Wald(1) = 
2.61, P = .11 (Table 5).
Discussion
The ALDEA SMA program, a culturally adapted, com-
munity-based SMA model, provided in 2 different com-
munity clinics was successful in reducing A1C among a 
socioeconomically and ethnically diverse group of patients.
The impact on A1C was clinically and statistically 
significant. The ALDEA SMA intervention led to a sta-
tistically significant greater reduction in A1C at 3 and 6 
months compared to UPC patients. The SMA patients 
had an additional A1C drop of –0.71% at 3 months and 
–0.80% at 6 months, compared to those in UPC. The 
UKPDS provides us with a context to understand the 
clinical significance of these findings. The UKPDS dem-
onstrated that a 1% decrease in A1C represents a 14% 
decrease in the risk of future macrovascular disease, 37% 
decrease in microvascular complications, and a 21% 
decrease risk of deaths related to diabetes.16
Furthermore, it is interesting that clinic site was a sig-
nificant predictor in A1C reduction 6 months, in favor of 
clinic site 1, which offered weekly SMA groups. This may 
point to an important factor to consider when planning the 
periodicity of the program. Perhaps having it available on 
a weekly basis allowed for a higher level of engagement 
among participants. Currently, the exact mechanism for the 
improvement seen in A1C in the ALDEA SMA is unknown. 
Future research may evaluate factors that contribute to 
behavioral change. It is likely a combination of increased 
access to care and intensification of treatment in synergy 
with psychosocial and education support. Language con-
cordance might also be a significant factor. It is well estab-
lished that language and cultural concordance between 
providers and patients increase health outcomes for patients 
Table 4
Changes in AIC at 3 Months and 6 Months: SMA Participants Versus Control Participants (Controlling for Baseline AIC)a
SMA Predicting AIC Changeb n b SE β t Statistic P Model Statistics
At 3 months  85 −0.71 −0.19 −2.23 .03 F(3, 82 ) = 14.7, P = .00
At 6 months 101 −0.80 −0.21 −2.34 .02 F(3, 98 ) = 11.5, P = .00
aIntervention (SMA = 1, control = 0). SMA, shared medical appointment.
bChange is defined as AIC at 3 months or at 6 months minus baseline AIC.
Table 5
SMA Predicting LDL and BP at Goal: SMA Versus Control 
at 6 Monthsa
n b SE β Wald P
BP 127 0.27 0.45 0.36 .55
LDL 125 0.64 0.40 2.61 .11
aIntervention (SMA = 1, control = 0). BP, blood pressure; LDL, low density 
lipoprotein; SMA, shared medical appointment.
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with chronic conditions, including diabetes.24 In rural set-
tings, oftentimes, there are few providers who speak mul-
tiple languages. Some of the patients had concordance with 
their primary care provider in the usual care group, whereas 
all of ALDEA SMA patients did since this program was 
delivered by language-concordant providers.
Although this study was novel and had important 
clinical findings, there were limitations. The design did 
not randomize the patients to the SMA intervention 
group or UPC control groups. Patients self-selected to 
enroll in the SMA, which may have led to selection bias. 
Although the design matched participants by A1C and 
age, there are many other potential variables that could 
have influenced the results that are not accounted for in 
this design. Despite this, results from this study provide 
the foundation for designing a more rigorous, prospec-
tive randomized trial in the future.
Another limitation is the threat to internal validity. It is 
possible that there was a design contamination since the 
treatment and UPC control groups were at the same clinic 
and for many of the patients, the medical providers 
crossed over from SMA to UPC. Furthermore, the imple-
mentation of the ALDEA SMA program might have influ-
enced primary care providers to intensify treatment and 
education efforts of the control patients. This bias could 
have underestimated the outcomes found in the study.
Despite its limitations, this study contributes to the 
existing literature and corroborates the finding of the first 
ALDEA SMA study as evidence of the effectiveness of 
the SMA model in reducing A1C among ethnic minority 
and medically underserved populations.15 Future research 
should include a more rigorous methodology, such as 
randomized control studies, and aim to include large 
samples that would provide sufficient power for the 
exploration of which elements within the SMA contrib-
ute the most toward positive behavioral changes and 
improvement in metabolic outcomes.
The ALDEA model has been successfully adapted and 
implemented in low-resource settings where large multi-
disciplinary professional teams are not financially sus-
tainable. This study provides us with evidence that a 
small multidisciplinary team lead by 1 provider (MD or 
NP) with the support of a medical assistant and health 
educator can bring about significant improvements in 
A1C among medically underserved people living with 
type 2 diabetes. Thus, the ALDEA SMA model has the 
potential to reduce health disparities in diabetes out-
comes among medically underserved communities.
Recommendations
The implementation of the ALDEA program in FQHCs 
provided valuable lessons to be considered in future inter-
ventions. First, it reinforced the value of language and 
cultural concordance between patient population and pro-
vider team. It demonstrates that programs that consider 
structural barriers can be successful. In this case, an open 
enrollment and a late policy that explicitly permitted late 
arrivals provided the flexibility needed for patient popula-
tions facing many structural barriers. Lastly, it reinforced 
the importance of an empowerment framework to increase 
patient activation and participation in DSMES programs. 
In sum, the ALDEA program demonstrated that medically 
underserved patients are eager to participate in commu-
nity interventions that remove structural and cultural bar-
riers to care. Educational programs must consider cultural 
and structural barriers in their program design.
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